India to United States: Metformin Export Trade Route
India has recorded 3,889 verified shipments of Metformin exported to United States, representing a combined trade value of $180.6M USD. This corridor is served by 38 active Indian exporters, with an average shipment value of $46.4K USD. The leading Indian exporter is GRANULES INDIA LIMITED, which accounts for 60% of total export value with 2,114 shipments worth $107.8M USD. On the buying side, GRANULES PHARMACEUTICALS INC is the largest importer in United States with $36.6M USD in purchases. The top 3 suppliers — GRANULES INDIA LIMITED, INVENTIA HEALTHCARE LIMITED, ZYDUS LIFESCIENCES LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Metformin corridor is one of India's established pharmaceutical export routes, with 3,889 shipments documented worth a combined $180.6M USD. The route is dominated by GRANULES INDIA LIMITED, which alone accounts for roughly 60% of all export value, reflecting the consolidated nature of India's metformin manufacturing sector.
Across 38 active suppliers, the average shipment value stands at $46.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with metformin's non-urgent bulk-order profile.
Shipment activity peaks during April-June, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 12.0%, placing it at rank #1 among India's top metformin export destinations globally.
On the import side, key buyers of Indian metformin in United States include GRANULES PHARMACEUTICALS INC, GRANULES PHARMACEUTICALS, INC, ASCEND LABORATORIES LLC and 94 others. GRANULES PHARMACEUTICALS INC is the single largest importer with 625 shipments valued at $36.6M USD.
